title: [Sclerosing peritonitis following continuous ambulatory peritoneal dialysis].
abstract: Sclerosing peritonitis is a severe complication after CAPD treatment. The visceral peritoneum is thickened and interenteric adhesive parts are found. Myofibroblasts are proliferated and the collageneous tissue is hyperplastic. The mean clinical symptom is the mechanical obstruction of the small bowel. We observed this illness in three out of sixty patients under CAPD. These patients had higher incidence of bacterial peritonitis. In the ascites high concentrations of PG E2 and Thromboxan B2 were observed. After treatment of the infection the concentrations fell down to normal values. Electronoptical observations from peritoneal biopsies showed a proliferation of myofibroblasts and extracellular lysosomes. It is known from these lysosomes that they are able to set free proteasis. These lead to degredation of fibrin and fibrinogen. These splits are mitogen to myofibroblasts. release from HIT cells could also be evoked by the sulphonylureas glibenclamide and tolbutamide and by an increase in concentration of extracellular K+ to 40 mmol/l. The content of cyclic AMP in HIT cells was increased modestly by glucose but not by an increase in extracellular K+. Forskolin elicited a 4-fold increase in cyclic AMP content. We conclude that HIT cells retain the essential features of the insulin secretory response of normal B cells and represent an important tool for further biochemical characterisation of the secretory system.
authors.forename: H
authors.initials: H
authors.lastname: Wilms
authors.forename: H B
authors.initials: HB
authors.lastname: Steinhauer
authors.forename: U N
authors.initials: UN
authors.lastname: Riede
authors.forename: G
authors.initials: G
authors.lastname: Kirste
mesh_terms: D000328:Adult; D001424:Bacterial Infections / Q000473:pathology; D015232:Dinoprostone; D005260:Female; D005337:Fibrin / Q000378:metabolism; D006801:Humans; D007415:Intestinal Obstruction / Q000473:pathology / Q000601:surgery; D007421:Intestine, Small / Q000473:pathology / Q000601:surgery; D008297:Male; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010537:Peritoneum / Q000473:pathology; D010538:Peritonitis / Q000209:etiology* / Q000473:pathology / Q000601:surgery; D011458:Prostaglandins E / Q000378:metabolism; D012598:Sclerosis; D013929:Thromboxane B2 / Q000378:metabolism
chemical_list: D011458:Prostaglandins E; D013929:Thromboxane B2; D005337:Fibrin; D015232:Dinoprostone
vernacular_title: Die sklerosierende Peritonitis nach kontinuierlicher ambulanter Peritoneal-Dialyse (CAPD).